Concerns on the Munich District Court decisions on SPC

The first judgement on the Supplementary Protection Certificate (SPC) manufacturing waiver issued by the Munich District Court, Germany in October 2023 caused a deep concern among the generic and biosimilar industry, as highlighted in a note from Medicines for Europe

MedTech Europe comments the political agreement on the PLD directive

After the political agreement on the revision of the Product Liability Directive (PLD), reached on 14 December 2023 by the European Council and Parliament, new concerns were expressed by MedTech Europe on behalf of the European medical technology sector


How to boost R&I and attract more talents

The political agreement reached by the European Council on the final text of the Recommendation on a European framework to attract and retain research, innovation and entrepreneurial talents in Europe updates the 2011 R1-R4 profiles for researchers, and introduces the European Charter for Researchers, a revision of the 2005 European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers

EU Parliament, a study on investments for Covid-19 Vaccines

A study prepared for the special COVI committee of the European Parliament shares light on how the great amount of funds for the development of Covid-19 vaccines was used for R&D and the expansion of the production capacity. Nine different vaccines have been examined, and comparisons have been also made with the US situation


  • Supplemento to n.1 - January 2024 NCF International 2024
  • Supplemento al n.8 - Ottobre 2023 NCF International 2023